FDA Inspection 1155582 — MW Encap Ltd.(NextPharma Edinburgh)

MW Encap Ltd.(NextPharma Edinburgh) — FEI 3005910213

The FDA completed an inspection of MW Encap Ltd.(NextPharma Edinburgh) on February 9, 2018 in Livingston. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 9, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Livingston (United Kingdom)

Additional Details

Mutual Recognition Agreement (MRA)